hh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infection
Southern Medical University, Guangzhou, PR China.
Southern Medical University, Guangzhou, PR China.
Sun Yat-sen University, Guangzhou, PR China.
Chinese Academy of Sciences, Shanghai, PR China.
Show others and affiliations
2018 (English)In: Journal of Pharmacological Sciences, ISSN 1347-8613, E-ISSN 1347-8648, Vol. 138, no 4, p. 247-256Article in journal (Refereed) Published
Abstract [en]

Dengue virus (DENV) annually infects 400 million people worldwide. Unfortunately, there is lack ofwidely protective vaccine or drugs against DENV. The viral RNA-dependent RNA polymerase (RdRp) ofNS5 protein is highly conserved among different DENV subtypes, thus presenting itself as an attractivetarget for drug design. In the current research, SPRi was performed to screen compounds against DENV2RdRp and 5(1H)-Quinazolinone,2-(4-bromophenyl)-2,3,4,6,7,8-hexahydro-7,7-dimethyl-1,3-diphenyl(Q63) was successfully screened out with a KD of 0.9 mM. Then, ITC and molecular docking assay wasperformed to access the binding mechanism between Q63 and DENV2 RdRp. Meanwhile, Q63 alsodecreased the intermediate dsRNA production, which was the product of RdRp. Further the antiviraleffects of Q63 were evaluated on mosquito C6/36 cells and mammalian BHK-21 cells. Q63 reduced CPEand cell toxicity effect after DENV2 infection on C6/36 and BHK-21 cells, with an EC50 of 2.08 mM. Time ofaddition assay revealed that Q63 affected the early genome RNA replication stage, including genome RNAreplication. In addition, Q63 down-regulated STAT1 phosphorylation, ISG15 and ISG54 after DENV2infection. In summary, Q63 was found to be a novel RdRp non-nucleoside inhibitor and a potential leadcompound for coping with DENV infectious disease in the future. © 2018 The Authors. 

Place, publisher, year, edition, pages
Amsterdam: Elsevier, 2018. Vol. 138, no 4, p. 247-256
Keywords [en]
DENV2 infection, Quinazolinone derivative, RdRp inhibitor
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:hh:diva-48394DOI: 10.1016/j.jphs.2018.06.012ISI: 000453009900004PubMedID: 30518482Scopus ID: 2-s2.0-85057540667OAI: oai:DiVA.org:hh-48394DiVA, id: diva2:1703118
Note

The Natural Science Foundation of China (81603118, 81700854),Medical Scientific Research Foundation of Guangdong Province(A2016119), Guangdong Provincial Application TechnologyResearch and the Development Project (2016B020237005), PearlRiver Nova Program of Guangzhou (201806010119), Natural ScienceFoundation of Guangdong Province (2017A030313717) supportedthis work. 

Available from: 2022-10-12 Created: 2022-10-12 Last updated: 2022-11-29Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Nandakumar, Kutty Selva

Search in DiVA

By author/editor
Nandakumar, Kutty Selva
In the same journal
Journal of Pharmacological Sciences
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 8 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf